Search

Search Constraints

You searched for: Author/Creator Bronze, Michael S.

Search Results

1. Alternative splice variants of DCLK1 mark cancer stem cells, promote self‐renewal and drug‐resistance, and can be targeted to inhibit tumorigenesis in kidney cancer. Issue 5 (16th April 2018)